Similarly, Trastuzumab-mediated ADCC of NK cells was enhanced by the addition of IL-21 against both high HER2- and low HER2-expressing ESCC (Figure 4B). The gene discussed is ERBB2; the disease is esophageal squamous cell carcinoma.